Key result
Transcatheter Aortic Valve Implementation (TAVI) significantly decreased the mean level of general depression from 4.19 to 3.12 and reduced the frequency of depressive symptoms from 20% to 3% at one-year follow-up.
Why the study?
One in three elderly patients undergoing valve implementation or surgical aortic valve replacement has depressive symptoms, but the impact of health-related quality of life on depressive symptoms in patients undergoing TAVI remained to be evaluated.
Does TAVI improve depressive symptoms and quality of life in elderly patients?
Cross-Sectional (n=131)
Does TAVI improve depressive symptoms and quality of life in elderly patients?
Answers are grounded in this paper and cite their sources.
TAVI is associated with a significant reduction in depressive symptoms and an improvement in quality of life in elderly patients, highlighting the importance of psychological screening.
Quality of life is an important factor influencing mood. In any group of elderly people undergoing valve implementation or surgical aortic valve replacement, one in three will have depressive symptoms. The aims of this study were as follows: 1. to evaluate the impact of health-related quality of life on depressive symptoms in elderly patients undergoing TAVI, and 2. to analyze beliefs about TAVI. Methods: A total of 131 elderly people (mean age: 82.1 ± 6.1 years) scheduled to receive TAVI completed the Geriatric Depression Scale, EQ-5D-3L, and Mini Mental State Examination. A total of 43 patients completed the questionnaires after the treatment. The narrative interview analyses were performed based on 20 randomly selected patients after TAVI. Results: The mean level of general depression before TAVI was 4.19 ± 2.83, and after it was 3.12 ± 2.52 (p = 0.02), and the frequency decreased from 20% to 3%. An increase in the level of activity and number of interests and a decrease in life satisfaction were identified. The higher the general quality of life was, the lower the levels of depressiveness before and after TAVI were (r = 0.26 vs. r = 0.48; p < 0.05). Conclusions: Patients differed in their depressive symptoms, as well as their intensity and frequency, before and after TAVI. These results underscore the importance of screening for depression at baseline and reassessing changes in depressiveness during follow-up.
No takes yet. Share an insight, caveat, or question.
Olszewska-Turek et al. (2022) conducted a cross-sectional in Severe symptomatic aortic stenosis (n=131). Transcatheter Aortic Valve Implementation (TAVI) vs. Baseline (before TAVI) was evaluated on Mean level of general depression (GDS-SF total score) (p=0.02). Transcatheter Aortic Valve Implementation (TAVI) significantly decreased the mean level of general depression from 4.19 to 3.12 and reduced the frequency of depressive symptoms from 20% to 3% at one-year follow-up.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: